Filters
German Parliament (Bundestag) extends deadline for reimbursement of wound care products until 2 December 2025
Understanding Subscription Contracts between Game Companies and Consumers in Germany
Expanding your Toolkit: A Guide to Open Source for Game Developers
Current changes to supply chain due diligence obligations, sustainability reporting and CO2 offsetting mechanism
Episode 5: How is substantive law developing in the Unified Patent Court (UPC)?
In this episode Paul England is joined by Marie Keup, Matthew Royle and Verena Bertram.
6 of 10 Podcasts
Fintech in Wealth Management: The new reality
Work/Life - international employment news update
New product liability risks for AI products
The new Product Liability Directive aims to modernise the product liability rules and remove obstacles for consumers. What should life sciences companies using AI in products know about the new product liability rules.
5 of 10 Insights
Purpose limitation and data minimisation: key considerations for AI training in the life sciences sector
The use of real-world evidence data to train AI models is becoming a critical component in advancing research and drug development. We explore how two of the GDPR's guiding principles are more than just regulatory requirements.
3 of 10 Insights
Selecting your AIA notified body
Manufacturers/providers of medical devices that, according to the EU AI Act, include a high-risk AI system (HRAIS) require a notified body assessment of their technical documentation and/or quality management system should urgently consider which notified body to appoint.
6 of 10 Insights
Data privacy in AI due diligence
AI has become an integral part of business operations across various industries. Its deployment demands careful legal and strategic considerations. Before integrating AI systems in a company’s workflows, thorough diligence should be conducted.
7 of 10 Insights